It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...

Randomized Phase 2 study initiated evaluating the combination of casdozokitug, toripalimab and bevacizumab in patients with liver cancer ...

For many people with early breast cancer (eBC), remission doesn’t mean everything goes back to normal. There are scars from ...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either ...

Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...

Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...

Ensartinib has received FDA approval for the first-line treatment of anaplastic lymphoma kinase (ALK)-positive locally ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

An immunofluorescence image of an aged mouse liver. Expression of β-galactosidase ... Metastasis remains the primary ...

Title: Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways with casdozokitug in combination with atezolizumab and bevacizumab in patients with unresectable, ...